Uterine myoma. D25.9Leiomyoma of uterus, unspecified
Conditions
Interventions
Intervention 1: Intervention group: received vitamin D 50,000 IU every 2 weeks for 10 weeks (Iranian Zahravi Corp.). Intervention 2: Control group: Received placebo with same color and shape of vit d
Treatment - Drugs
Placebo
Intervention group: received vitamin D 50,000 IU every 2 weeks for 10 weeks (Iranian Zahravi Corp.)
Control group: Received placebo with same color and shape of vit d in intervention group
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 49 Years
Inclusion criteria
Inclusion criteria: Having 1 to 2 uterine leiomyomas with size 20-80 mm Serum levels of 25-hydroxyvitamin D3 <20 ngr/ml. Signed a inform consent form to participate in the study
Exclusion criteria
Exclusion criteria: Consuming hormonal drugs Massive vaginal bleeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uterine myoma size. Timepoint: Before the intervention begins and 6 months after the intervention begins. Method of measurement: X8 medison ultrasound machine. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum vitamin D levels. Timepoint: Before intervention and 6 months after intervention. Method of measurement: Radioimmunoassay. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Ansari
Esfahan University of Medical Sciences
Outcome results
None listed